| 查看: 174 | 回复: 0 | |||
ienjoysun兑换贵宾
|
[交流]
Novartis in talks to buy Gamida Cell for up to $600 million: report
|
|
Novartis in talks to buy Gamida Cell for up to $600 million: report (Ref: Globes, Jewish Business News, Fidelity) March 18th, 2014 By: Matthew Dennis Tags: Top Story StemEx Clal Biotechnology Gamida Cell Novartis Corporate Affairs Mergers & Acquisitions According to sources close to the matter, Novartis is in advanced discussions to buy Gamida Cell for as much as $600 million, Globes reported Tuesday. Elbit Medical Technologies, which has a 30.8-percent stake in Gamida, confirmed an offer from an unnamed company, noting that it includes a "significant immediate payment and additional future payments totalling hundreds of millions of dollars." Clal Biotechnology, which holds around 22 percent of Gamida, added that the bid was received on March 7. Gamida is developing stem cell therapies for a variety of conditions, including its StemEx treatment, which is being evaluated as part of a transplant regimen for patients with high-risk leukaemia and lymphoma. According to Elbit and Clal, future payments under the deal would depend on meeting development, registration and sales milestones. Globes noted that although talks with Novartis are at an advanced stage, Gamida has not abandoned plans for an initial public offering. The newspaper said that the valuation for the IPO is lower than the potential value of an acquisition, which would likely be the preferred option. http://www.firstwordpharma.com/node/1196136#axzz2wOds3Uam |
回复此楼» 猜你喜欢
药学349专硕求调剂
已经有2人回复
-
《左乙拉西坦注射液制备工艺研究、质量控制和稳定性研究》下载
已经有1人回复
-
药理学论文润色/翻译怎么收费?
已经有233人回复
-
105500药学求调剂，一志愿山东大学药学，348分
已经有3人回复
-
考试
已经有2人回复
-
【上海调剂急录】代码1007/1055/0806/0703./0780./0836等速点！！深造资源满格！
已经有9人回复
-
【调剂上岸】985联合培养！1007/1055/08..07..等，医药生化环材计算机，速来！
已经有5人回复
-
【上海调剂】985联合培养！别错过能送你去交大/同济/中科院的神仙导师！
已经有4人回复
-
【#上海调剂急录#】985联合培养！别错过能送你去交大/同济/中科院的神仙导师！
已经有9人回复
-
【#上海调剂急录#】985联合培养！代码1007/1055/08..07...等速来！！
已经有9人回复
